# AbbVie Inc. (ABBV) — Q4-2013 Earnings Results

**Report date:** 2014-01-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2013

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Up 1.9%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | N/A | -1.09% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their long-term strategy despite the slight EPS miss. They highlighted the potential of their product pipeline.

**Key quotes:**

> We remain focused on our long-term growth strategy.

> Our pipeline continues to show promise for future developments.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising by 1.9%. Investors may have been encouraged by management's focus on long-term growth and the potential of their product pipeline, despite the lack of revenue data and guidance updates.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2013_